SCHOTT Pharma AG & Co. KGaA (1SXP) - Total Liabilities

Latest as of September 2024: €650.00 Million EUR ≈ $759.92 Million USD

Based on the latest financial reports, SCHOTT Pharma AG & Co. KGaA (1SXP) has total liabilities worth €650.00 Million EUR (≈ $759.92 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

SCHOTT Pharma AG & Co. KGaA - Total Liabilities Trend (2020–2024)

This chart illustrates how SCHOTT Pharma AG & Co. KGaA's total liabilities have evolved over time, based on quarterly financial data. See working capital position of SCHOTT Pharma AG & Co. KGaA to evaluate short-term liquidity relative to the company's equity base.

SCHOTT Pharma AG & Co. KGaA Competitors by Total Liabilities

The table below lists competitors of SCHOTT Pharma AG & Co. KGaA ranked by their total liabilities.

Company	Country	Total Liabilities
MOBVISTA INC. DL-01 F:6MO	Germany	€587.56 Million
Coface SA PA:COFA	France	€5.87 Billion
Signify N.V. AS:LIGHT	Netherlands	€3.95 Billion
Ebos Group Ltd AU:EBO	Australia	AU$5.67 Billion
Margun Enerji Uretim Sanayi ve Ticaret AS IS:MAGEN	Turkey	TL7.70 Billion
Transportadora de Gas del Sur SA B BA:TGSU2	Argentina	AR$2.27 Trillion
Oyak Cimento Fabrikalari AS IS:OYAKC	Turkey	TL17.35 Billion
Valiant Co Ltd SHE:002643	China	CN¥3.02 Billion

Liability Composition Analysis (2020–2024)

This chart breaks down SCHOTT Pharma AG & Co. KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of SCHOTT Pharma AG & Co. KGaA.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.82	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.45	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SCHOTT Pharma AG & Co. KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SCHOTT Pharma AG & Co. KGaA (2020–2024)

The table below shows the annual total liabilities of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024.

Year	Total Liabilities	Change
2024-06-30	€650.00 Million ≈ $759.92 Million	+20.45%
2023-06-30	€539.65 Million ≈ $630.91 Million	+10.71%
2022-06-30	€487.46 Million ≈ $569.89 Million	+52.10%
2021-06-30	€320.48 Million ≈ $374.67 Million	+14.31%
2020-06-30	€280.36 Million ≈ $327.77 Million	--

About SCHOTT Pharma AG & Co. KGaA

XETRA:1SXP Germany Medical Instruments & Supplies

Market Cap

$2.94 Billion

€2.51 Billion EUR

Market Cap Rank

#5729 Global

#884 in Germany

Share Price

€16.68

Change (1 day)

-0.12%

52-Week Range

€12.96 - €28.50

All Time High

€41.20